SCHEMBL29809000

SCHEMBL29809000

O=c1ccc2nc3ccc(OCc4ccccc4)cc3oc-2c1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 13/20 0.79
CYP1A2 P05177 1/20 0.70
MAOB P27338 4/20 0.53
MAOA P21397 2/20 0.53
NPC1 O15118 2/20 0.53
MEN1 O00255 1/20 0.53
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
CA3 P07451 1/20 0.53
CA4 P22748 1/20 0.53
CA6 P23280 1/20 0.53
CA7 P43166 1/20 0.53
MTNR1A P48039 1/20 0.53
KMT2A Q03164 1/20 0.53
CA9 Q16790 1/20 0.53
CA14 Q9ULX7 1/20 0.53
SLC16A3 O15427 1/20 0.47
ACHE P22303 1/20 0.47
RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL563335 1.00 APP (0.79) APPCYP1A2MAOBMAOANPC1
SCHEMBL1093700 0.91 APP (0.67) APPCYP1A2MAOBMAOANPC1
SCHEMBL19627050 0.89 APP (0.78) APPCYP1A2MAOBMAOAACHE
SCHEMBL1104921 0.88 APP (1.00) APPCYP1A2NPC1MEN1KMT2A
SCHEMBL18467806 0.88 APP (0.80) APPCYP1A2MAOBMAOANPC1
SCHEMBL10167879 0.88 APP (0.80) APPCYP1A2MAOBMAOANPC1
SCHEMBL19627047 0.88 APP (0.70) APPCYP1A2
SCHEMBL10167864 0.87 APP (1.00) APPCYP1A2MAOBMAOANPC1
SCHEMBL23623803 0.85 APP (0.78) APPCYP1A2MAOBMAOANPC1
SCHEMBL19630615 0.85 APP (0.75) APPCYP1A2MAOBMAOANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3741760-B1 COMPOUNDS, PROCESS FOR OBTAINING THE COMPOUNDS, PHARMACEUTICAL COMPOSITION, USE OF THE COMPOUNDS AND METHOD FOR TREATING PSYCHIATRIC DISORDERS AND/OR SLEEP DISORDERS ACHE LABORATORIOS FARMACEUTICOS SA (BR) 2024-12-04 EP disclosed
CN-118525105-A High ATP affinity proteins and inhibitors thereof as targets for treatment of refractory molecular subtype cancers 维拉沃斯公司 2024-08-20 CN disclosed
US-11945864-B2 Monoclonal antibody specifically binding to LAG-3 and use thereof Y-Biologics Inc. (KR) 2024-04-02 US disclosed
EP-3529234-B1 COMPOUNDS, PROCESS FOR OBTAINING THE COMPOUNDS, PHARMACEUTICAL COMPOSITION, USE OF THE COMPOUNDS AND METHOD FOR TREATING PSYCHIATRIC DISORDERS AND/OR SLEEP DISORDERS ACHE LABORATORIOS FARMACEUTICOS SA (BR) 2023-11-29 EP disclosed
EP-4132975-A1 MONOCLONAL ANTIBODIES AND ANTIGEN BINDING FRAGMENTS THEREOF FOR SUPPRESSING CD73 IMMUNE CHECKPOINT AND USES THEREOF Aprilbio Co., Ltd (KR) 2023-02-15 EP disclosed
CN-115181108-A Compound and preparation method, pharmaceutical composition and application thereof 艾奇实验室制药有限公司 2022-10-14 CN disclosed
CN-110088092-B Compounds, processes for their preparation, pharmaceutical compositions, uses of compounds and methods for treating psychiatric and/or sleep disorders 艾奇实验室制药有限公司 2022-10-04 CN disclosed